Removing plasmin from the equation – Something to chew on… by Morrow, GB, Mutch, NJ

UTP is not a biased agonist at human P2Y11 receptors by Morrow, GB, Nicholas, RA, Kennedy, C

A serpin with a finger in many PAI’s: PAI-1’s central function in thromboinflammation and cardiovascular disease by Morrow, GB, Whyte, C, Mutch, N

Functional plasminogen activator inhibitor 1 is retained on the activated platelet membrane following platelet activation by Morrow, GB, Whyte, CS, Mutch, NJ

Fibrinolytic abnormalities in acute respiratory distress syndrome (ARDS) and versatility of thrombolytic drugs to treat COVID-19 by Whyte, CS, Morrow, GB, Mitchell, JL, Chowdary, P, Mutch, NJ

Fibrinogen replacement therapy for traumatic coagulopathy: Does the fibrinogen source matter? by Morrow, GB, Carlier, MSA, Dasgupta, S, Craigen, FB, Mutch, NJ, Curry, N

Coagulation status of critically ill patients with and without liver disease assessed using a novel thrombin generation analyser by Morrow, GB, Beavis, J, Harper, S, Baker, P, Desbourough, MJR, Curry, N, Stanworth, SJ, Laffan, MA

Exposure of plasminogen and the novel plasminogen receptor, Plg-RKT, on activated human and murine platelets by Whyte, CS, Morrow, GB, Baik, N, Booth, NA, Jalal, MM, Parmer, RJ, Miles, LA, Mutch, NJ

Cryoprecipitate transfusion in trauma patients attenuates hyperfibrinolysis and restores normal clot structure and stability: results from a laboratory sub-study of the FEISTY tria... by Morrow, GB, Feller, T, McQuilten, Z, Wake, E, Ariëns, RAS, Winearls, J, Mutch, NJ, Laffan, MA, Curry, N

The suboptimal fibrinolytic response in COVID-19 is dictated by high PAI-1 by Whyte, CS, Simpson, M, Morrow, GB, Wallace, CA, Mentzer, AJ, Knight, JC, Shapiro, S, Curry, N, Bagot, CN, Watson, H, Cooper, JG, Mutch, NJ